| Poster Title |
|---|
| MDS, AML and ALL |
| A More Than 3-Year Long and Ongoing Remission After Early Administration of Gilteritinib Monotherapy in HMA–Venetoclax and Midostaurin Molecular Failure in an Elderly FLT3-ITD Mutated AML Patient Ebrar Uzunabdullah1, Süreyya Yiğit Kaya2, Yaşa Gül Mutlu3, Ömür Gökmen Sevindik4 1BasaksehirCam and Sakura City Hospital; 2Istanbul Medipol University, Medipol Mega University Hospital, Department of Hematology; 3Gaziantep City Hospital, Department of Hematology; 4Istanbul Demiroglu Bilim University, Istanbul Florence Nightingale Hospital, Department of Hematology, Istanbul Video |
| AGE-RELATED DISPARITIES IN AML: A SINGLE-CENTER COMPARATIVE ANALYSIS OF CLINICAL CHARACTERISTICS AND OUTCOMES IN ADOLESCENTS/YOUNG ADULTS VERSUS OLDER ADULTS Dana Albaghdadi, Omar Shahin, Tamer Al-Batsh, Rand Haddadin, Kamal Al-Rabie, Waleed Dana, Lina Marie, Mohammad Makoseh, Zaid Abdelrahman, Abdelraheem Yaqoub King Hussein Cancer Center, Amman, Jordan Video |
| Analysis of rs4590952 Polymorphism (p53-RE KITLG) in Acute Leukemias and its Association with AML Therapy Response Starchenko S.E., Risinskaya N.V., Bessmertnyy D.K., Abdulpatakhov A.S., Kulikov S.M., Sudarikov A.B., Parovichnikova E.N. National Research Center for Hematology, Moscow, Russia Video |
| BCR-ABL POSITIVE CHRONIC MYELOID LEUKEMIA TYPE ACUTE LYMPHOBLASTIC LEUKEMIA PRESENTING AS DE NOVO B-ALL Mark Podberezin Department of Pathology and Laboratory Medicine, Maimonides Medical Center, Brooklyn, NY, USA and State University of New York (SUNY Downstate), Brooklyn, NY. USA Video |
| Introduction of Treatment for Children with ALL in a Resource Limited Hospital in Cambodia Sam Lyvannak, Bun Sereyleak, Katherine Tarlock Angkor Hospital for Children, Seattle Children’s Hospital Video |
| LET-7B AS A METABOLIC GATEKEEPER IN AML: From Metabolic Reprogramming to Differentiation Therapy Vijay Prasad Koppineedi, Ravi Kumar Gutti Department of Biochemistry, University of Hyderabad, Hyderabad, India |
| Luspatercept in Low-Risk MDS with Ring Sideroblasts (MDS-RS): a Long-Term Real-life experience A.M. Maddaloni1, C. Quagliano1, S. Leone2, M. DiPerna3, D. DeNovellis4, I. Ferrara4, A. Malandrini4, C. Frieri5, G. Gaeta5, A. D’Ambrosio6, P. Della Cioppa7, T. Izzo2, N. Pugliese1, S. Avilia1, F. Grimaldi1, F. Pane1, M. Memoli1 1Hematology and Hematopoietic Stem Cell Transplant Center, University of Naples FedericoII, Naples; 2AORN Cardarelli, Naples; 3A. Tortora Hospital, Pagani; 4Hematology and Transplant Center, University Hospital San Giovannidi Dioe Ruggi d’Aragona, Salerno; 5Hematology and Bone Marrow Transplant Unit AORNS. Giuseppe Moscati Avellino; 6AO Sant’Annae San Sebastiano, Caserta; 7ASLNA1-Hospital Loreto Mare, Naples, Italy |
| Machine Learning–Driven Significance Assessment of Genomic Aberrations Associated with MRD-Positive Remission in B-ALL Surimova V., Risinskaya N., Kotova E., Abdulpatakhov A., Vasileva A., Chabaeva Y., Starchenko S., Aleshina O., Kapranov N., Galtseva I., Ponomareva A., Kanivets I., Korostelev S., Kulikov S., Sudarikov A., Parovichnikova E. National Medical Research Cetner for Hematology, Moscow; Moscow Technical University of Communications and Informatics, Moscow, Russia Video |
| PAVE-T: POST-ALLOGENEIC HSCT AZACITIDINE–VENETOCLAX MAINTENANCE YIELDS DURABLE REMISSIONS IN HIGH-RISK T-ALL Sara El Mustapha, Mohamad Hadi El Charif, Nour Moukalled, Jean El Cheikh, Ali Bazarbachi, Iman Abou Dalle Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon Video |
| Prognostic Value of Early Peripheral Blood Clearance in Hyperleukocytic AML Nesrine Chihaoui1, Kharrat Rachid1, Ben Neji Hend1, Selmi Amany1, Rabeb Berred1, Bchir Manel1, Achour Mariem1, Cherni Rym1, Ben Lakhal Fatma2, Feki Sarra2, Ayed Wiem3, Gouider Emna 2, Ben Lakhal Raihane1 1Department of Clinical Hematology and 2Laboratory of Hematological Biology, Aziza Othmana Hospital Tunis; 3Depatment of Histology and Medical Cytogenetics, Pasteur Institute of Tunis, Tunisia Video |
| Subgroup Analysis by Fitness Criteria of Patients with BPDCN Treated with 1L TAG Cristina Papayannidis1, Naveen Pemmaraju2, Marco Herling3, Kendra L. Sweet4, Anthony S. Stein5, Sumithira Vasu6, Todd L. Rosenblat7, David A. Rizzieri8, Eunice S. Wang9, Marina Konopleva10, Michael Zuurman11, Alessandra Tosolini12, Muzaffar Qazilbash2, Andrew A. Lane13 1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy; 2The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 3University Hospital Leipzig and Cancer Center Central Germany (CCCG) Leipzig-Jena, Germany; 4Moffitt Cancer Center, Tampa, FL, USA; 5City of Hope, Duarte, CA, USA; 6The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA; 7Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY, USA; 8Novant Health Cancer Institute, Charlotte, NC, USA; 9Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA; 10Albert Einstein College of Medicine/Montefiore Cancer Center, Bronx, NY, USA; 11Menarini Group, Machelen, Belgium; 12Menarini Group, New York, NY, USA; 13Dana-Farber Cancer Institute, Boston, MA, USA Video |
| T/MYELOID MPAL WITH BZIP CEBPA MUTATIONS: A GENETICALLY AND BIOLOGICALLY DISTINCT SUBTYPE OF MPAL Lingaraj Nayak1,4, Gaurav Chatterjee3,4, Manju Sengar1,4, Bhausaheb Bagal1,4 Hasmukh Jain1,4, Alok Shetty1,4, PG Subramanian3,4, Prashant Tembhare3,4, Nikhil Patkar3,4, Sweta Rajpal3,4, Sachin Punatar2,4, Anant Gokarn2,4, Sumeet Mirgh2,4, Nishant Jindal2,4, Navin Khattry2,4 1Department of Medical Oncology, Tata Memorial Hospital; 2BMT Unit, Department of Medical Oncology, ACTREC; 3Department of Hematopathology, Tata Memorial Hospital; 4HBNI, Mumbai, India Video |
| Tumor LYSIS Syndrome in adult ALL Philadelphia chromose negative: A monocentric study Ben Alaya Y., Achour M., Kharrat R., Cherni R., Ben Neji H., Ben Lakhal R. Aziza Othmana Hospital, Adult Clinical Hematology Department Video |
| Lymphoma |
| Clinical characteristics and outcomes in Human immunodeficiency virus – associated lymphomas: A retrospective Study Agnieszka Giza1, Magdalena Zapała2, Marta Głuchowska2, Paulina Ceklarz2, Dagmara Zimowska-Curyło1, Tomasz Sacha1, Monika Bociąga-Jasik3 1Department of Hematology, Jagiellonian University Medical College, Faculty of Medicine; 2Haematologyand Internal Medicine Clinical Department, The University Hospital; 3Department of Infectious Diseases and Tropical Medicine, Jagiellonian University Medical College, Faculty of Medicine and Clinic of Infectious Diseases Clinical Department, The University Hospital, Kraków, Poland Video |
| Clinicopathological correlation in cases of Plasmablastic lymphoma Harshita Dubey, Amar Ranjan, Pranay Tanwar Lab Oncology, Dr.B.R.A.IRCH, AIIMS, New Delhi, India |
| Epidemiological and clinicopathologic features of T-cell lymphomas: a single-center experience S. Khirallah, W. Miled, H. Cherif, M. Sayadi, R. Mansouri, K. Kacem, R. Ben Lakhal Clinical Hematology Department, Aziza Othmana’s Hospital, Tunis, Tunisia |
| Hepatosplenic T-cell Lymphoma in a Young Female: Diagnostic and Therapeutic Challenges in a Rare Aggressive Entity María Pacheco Rodríguez Hospital Universitario Morales Meseguer Murcia Video |
| Induction Therapy with the BV-AVD Regimen: Real-World Data Focused on Toxicity Deniz Özmen, Batuhan Bulan, Ali Ahadzade, Güldane Zülfaliyeva, Fazıl Burak Dilek, Buğse Güle Zengin, Melis Özer Çerme, Tuba Özkan, Muhlis Cem Ar Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, Division of Hematology Video |
| LENALIDOMIDE MAINTENANCE THERAPY AFTER AUTOLOGOUS SCT IN RELAPSED AND/OR REFRACTORY NON-HODGKIN’S LYMPHOMA Mohamad Hadi El Charif, Adbdallah Yassine, Nour Moukalled, Jean El Cheikh, Ali Bazarbachi, Iman Abou Dalle Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut, Lebanon Video |
| Navigating Frontline and Salvage Therapeutics in Blastic Plasmacytoid Dendritic Cell Neoplasm Manzoor Khan1, Syed Shahmeer Raza1, Ferdaws Abu Jalal2, David Waldron2, Maria Losa Maroto2, Abid Nawaz Khan Adil3,4 1Queen Elizabeth Hospital, Birmingham, UK; 2The Wright Center for Graduate Medical Education, Scranton, PA, USA; 3California Health Sciences University, Clovis, CA, USA; 4Internist-Fresno Heart & Surgical Hospital, Fresno, CA, USA |
| Overcoming R/R Hodgkin Lymphoma: A Case of Success with Pembrolizumab combined with Chemotherapy Nimra Zafar, Andrejs Ivanovs Department of Haematology, Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK Video |
| P2RX5 is a human B-cell marker and a multi-lineage immunotherapy target for lymphoid and plasma cell malignancies Zhiwei Ang1, Annette Castro1, Luca Paruzzo2, Carolin Schimdt1, Zainul S. Hasanali2, Katharina Hayer1 , Federico Stella2, Samantha Soldan2 , Manuel Torres-Diz1,Christopher Kwok2, Patricia King Sainos2, Kayla Ji2, Patrick Krohl3, Justyn Fine3, Priyanka Sehgal1, Dan Martinez2, Anupma Nayak2, Jamie B. Spangler3, James L Riley2, Dan T. Vogl2; Patrizia Porazzi2, Paul M. Lieberman2, David Allman2, Marco Ruella2, Andrei Thomas-Tikhonenko1,2 1Children’s Hospital of Philadelphia, PA; 2University of Pennsylvania, Philadelphia, PA; Johns Hopkins University, Baltimore, MD |
| Redefining Risk Assessment: Hasenclever Prognostic Variables as Predictors of Central Nervous System Infiltration in Hodgkin Lymphoma Patients Lucy González Villarroel Instituto Nacional de Cancerología and Hospital Regional 1° de Octubre, ISSSTE, Mexico City, Mexico |
| Relationship Between HIF-2α Overexpression and Molecular Subtypes of DLBCL: GCB Versus Non-GCB Desta Nur Ewika Ardini, Eko Adhi Pangarsa, Daniel Rizky, Hermawan Istiadi, Budi Setiawan, Damai Santosa, Catharina Suharti Haematology Oncology Staff Division, Department of Internal Medicine, Faculty of Medicine Diponegoro, University/Dr. Kariadi Hospital, Semarang Video |
| REMISSION OF R/R CLASSICAL HODGKIN LYMPHOMA INDUCED BY OFF-LABEL USE OF BRENTUXIMAB VEDOTIN AND BENDAMUSTINE COMBINATION FOLLOWED BY AUTOLOGOUS HSCT IN A YOUNG ADOLESCENT MALE: A CASE REPORT Reem Awad, Hadeel Ammar, Asma Al Olama Dubai Hospital, Dubai Academic Heatlh Corporation, Hematology, Dubai, UAE |
| Therapeutic Outcomes of Peripheral T-Cell Lymphoma: 11 years of Experience Haithem Cherif, Wafa Miled, Sabrine Khirallah, Malek Sayadi, Raoudha Mansouri, Karima Kacem, Raihane Ben Lakhal Aziza Othmana Hospital, Clinical Hematology Department, Tunis, Tunisi |
| MPN |
| DISENTANGLING THE PROGNOSTIC LANDSCAPE OF CHRONIC MYELOID LEUKEMIA: FROM EPIGENETIC REGULATORS TO INFLAMMATORY AND IMMUNE MARKERS Lidia Trombello1,2, Clara Bono2, Francesca Guerrini2, Sara Galimberti2 1Sant’Anna School of Advanced Studies, Pisa; 2University of Pisa, Italy |
| Distinct transcriptomic signatures of circulating monocyte subsets reveal reprogrammed immunopathogenic axes in MPNs Vitor Leonardo Bassan1, Rafaela de Freitas Martins Felício2, Fabíola Attié de Castro1 1School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo; 2Brith Defects Epidemiology Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil |
| First Philippine Report of Myeloproliferative Neoplasms with Concurrent JAK2 and BCR::ABL1 Mutations Rene A. Amadore Jr, Rowel David D. Yap, Anne Kristine H. Quero-Taggaoa Philippine General Hospital |
| Management and Clinical Outcomes of Congenital Erythrocytosis Patients: A Multicenter Descriptive Analysis of Patients from the UK and International Cohorts Iman AL Noumani1,2, Paola Guglielmelli3, Sarah Wexler4, Fiona Hickey 5, Andrew McGregor6, Simone Mueller 7, Ioannis Koutsavlis8, Alberto Alvarez-Larrán9, Paula Rodríguez-Gálvez10, Maria Victoria Cuevas Ruiz 11, Saša Anžej Doma12, Anna Angona Figueras13, Anita Arasaretnam14, Elena Magro Mazo 15, Rocío Zapata Bautista 16, Peter Dyer17, Gonzalo Carreño-Tarragona18, Álvaro Lorenzo Vizcaya19, Anna Godfrey20, Maria Dimopoulou 21, Claire Harrison1, Mary Frances McMullin22 1Guys and St Thomas’ Hospital, London, UK; 2Royal Hospital, Muscat, Oman; 3CRIMM, AOU Careggi, University of Florence, Florence, Italy; 4Royal United Hospitals NHS Foundation Trust, Bath, UK; 5Sheffield Children’s Hospital, UK; 6The Newcastle Upon Tyne Hospitals NHS Foundation Trust, UK; 7Kantonsspital Winterthur, Switzerland; 8Western General Hospital, NHS Lothian, Edinburgh, UK; 9Hospital Clínic, Barcelona, Spain; 10Hospital Clínico Universitario de Valencia, Spain; 11Hospital Universitario de Burgos, Spain; 12aUniversity Medical Centre Ljubljana, Hematology Department and 12bUniversity of Ljubljana, Faculty of Medicine, Slovenia; 13Institut Catalàd’Oncologia-Hospital Josep Trueta, Girona, Spain; 14UH Sussex NHS Trust, Brighton, UK; 15Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain; 16Hospital Juan Ramón Jiménez, Huelva, Spain; 17University Hospital North Midlands, Stoke on Trent, UK; 18Hospital Universitario 12 de Octubre, Madrid, Spain; 19Lucus Augusti University Hospital, Lugo, Spain; 20Cambridge University Hospital NHS Foundation Trust, UK; 21LaikonGeneral Hospital of Athens, Greece; 22Queen’s University, Belfast, Northern Ireland Video |
| Ropeginterferon-alfa 2b: A Paradigm Shift in Polycythemia Vera Management Bianca Constantin1, Mihaela Dragomir1, Cerasela Jardan1,2, D. Coriu1,2, Ana Manuela Crisan1,2 1Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest; 2Carol Davila University of Medicine and Pharmacy, Bucharest, Romania |
| SHORESPAN-007: A Randomized, Double-Blind, Phase 3 Study of Bomedemstat versus Hydroxyurea in Cytoreductive Therapy–Naive Essential Thrombocythemia N. Curto-Garcia1, D. Ross2, K. Pettit3, Y. Sugimoto4, E. Zimran5, Y. Shimomura6, H. Yamaguchi7, H. C. Hasselbalch8, H. Gill9, A. Berkovits10, A. Muzaffer Demir11, T.-Y. Chen12, S. Scheding13, C. Barrera Carmona14, A. M. Vannucchi15, K. Kirito16, S. Koschmieder17, S. Zhang18, U. Ogbu18, J. J. Kiladjian1 1Guy’s and St Thomas’ NHS Foundation Trust, London, UK; 2Royal Adelaide Hospital and SA Pathology, SA, Australia; 3Univeristy of Michigan, Ann Arbor, MI, USA; 4Mie University Graduate School of Medicine, Tsu, Japan; 5Hadassah Medical Center, Jerusalem, Israel; 6Kobe City Medical Center General Hospital, Japan; 7Nippon Medical School, Tokyo, Japan; 8Zealand University Hospital, Roskilde, Denmark; 9School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong, China; 10Immunocel, Santiago, Chile; 11Trakya University, Edirne, Türiye; 12National Center Cheng Kung University Hospital Clinical Trial Center, Tainan, Taiwan; 13Skånes Universitetssjukhus Lund, Sweden; 14Higiea Oncologia, Mexico City, Mexico; 15University of Florence, Italy; 16University of Yamanashi Hospital, Chuo, Japan; 17Faculty of Medicine, RWTH Aachen University, Germany; 18Merck & Co., Inc., Rahway NJ, USA; 19Hôpital Saint-Louis, Université Paris, Cité, France Video |
| Twists and Turns: Unmasking Myeloproliferative Neoplasms Through Surgical Complications of Wandering Spleen Rene A. Amadore Jr., Patrick Neil A. Guiao, Anne Kristine H. Quero-Taggaoa Philippine General Hospital |
| Transplantation |
| B-Lymphoblastic Lymphoma with Bilateral Kidney Involvement treated with Allogeneic SCT: A Case Report Pešić A.1, Bešević N.1, Ðunić I.1,2, Todorović Balint M.1,2 1Clinic for Hematology, University Clinical Center of Serbia, Belgrade; 2Faculty of Medicine, University of Belgrade, Serbia Video |
| Bayesian Weibull survival analysis of thalassemia major post-transplant outcomes Himanshu, M. Joseph John Department of Clinical Hematology, Christian Medical College and Hospital, Ludhiana, India Video |
| Comparative analysis of Pegfilgrastim and Filgrastim use in Myeloma Autografts Manzoor Khan, David Waldron, Omid Khyber, Ferdaws Abu Jabal, Sridhar Chaganti University Hospitals Birmingham, Queen Elizabeth Hospital, West Midlands, UK |
| CYTOMEGALOVIRUS REACTIVATION DID NOT IMPACT RELAPSE AFTER HAPLOIDENTICAL HSCT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE: A SINGLE-CENTER EXPERIENCE Mohammad Tarek1,2, Abdulrahman Habashy1,2, Ahmed Samy1, Hossam Abdeen1, Omar Emad1,2, Adham Gamal1, Mohamed Eissa1, Hazem Kraitem1, Nader Abdelaziz1, Mohamed Fathy1, Hesham Shaban1, Ahmed Ismael1, Khaled Zakareya1, Essam Khater1, Omar Abou El-Hasan1, Islam Elzaeem1, Islam Abdelwahed1, Moheb Tharwat1, Mohamed El-Safty1, Mohamed Negm1, Ahmed El-Husseiny1, Mohamed Elprince1, Hussein Hammam1, Ahmed Kasbar1, Sameh Emara1, Abdel Salaam Atallah1, Sherif Mahmoud1, George Baheig1, Mohamed Khalaf1 1Clinical Hematology and Bone Marrow Transplantation Department, Oncology & Hematology Hospital, Maady Military Medical Compound; 2Clinical Hematology Department, Armed Forces College of Medicine (AFCM), Cairo, Egypt |
| Donor chimerism in blood cells and free circulating plasma DNA in patients after allo-HSCT Olga E. Dubova, Natalya V. Risinskaya, Vera A. Vasilieva, Elena E. Nikulina, Anna A. Yushkova, Natalya A. Severina, Yulia V. Sidorova, Larisa A. Kuzmina, Andrey B. Sudarikov National Medical Research Center for Hematology, Moscow, Russia Video |
| Infectious Morbidity After Autologous SCT: A Prospective Cohort Study R. Farchoukh, K. El Akel, M. Ahnach, S. Ben Chekroun, M. Bendari Department of Clinical Hematology, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences, Casablanca, Morocco Video |
| NMR-based Metabolic profiling for monitoring cellular therapy outcomes Shivalika Sharma Bahukhandi1, Ravi Majhi2, Aditya Kumar Gupta2, Virendra Kumar1 1Department of NMR; 2Pediatrics, All India Institute of Medical Sciences, New Delhi, India Video |
| Setting Up a Gene Therapy Program: First Successful Administration of Gene Therapy for Hemoglobinopathy Patients in the UK: CRISPR-Based Gene Therapy for Transfusion-Dependent Beta-Thalassemia Mussawair Hussain, Nandini Sadasivam, Lucy Booth, Soka Chelsea, Farhan Ali Anjum Department of Clinical Haematology, Manchester Royal Infirmary Hospital Video |
| Specific Features of Vaccination Management in Allogeneic HSCT Patients: Experience of Cheikh Khalifa Hospital R. Farchoukh, H. Hadri, I Mourabiti, K. El Akel, H. Al Harrar, M. El Agal, Z. Guessouss, Z. Saad, Y. Zouiten, M. Ahnach, S. Ben Chekroun Department of Clinical Hematology, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences, Casablanca, Morocco Video |
| General Hematology |
| A Case Report of EMH in a Retroperitoneal Mass in a Non-Transfusion Dependent Beta-Thalassemia Patient Fatema A. Alnashaba Hematology, Salmaniya Medical Complex, Manama, BHR Video |
| A rare case of Atypical Hemolytic Uremic Syndrome Triggered by Influenza A Infection in an Elderly Patient Aya Gendeel, Yosra A. Taha, Ella Fernandes, Qasim A. Ali Department of General Medicine, Princess Royal University, King’s College NHS Hospitals, UK |
| A RARE CASE OF PRIMARY PLASMA CELL LEUKEMIA WITH RESPIRATORY INVOLVEMENT Abhinav Goswami, Harshita Dubey, Sanika Agrawal, Amar Ranjan All India Institute of Medical Sciences, New Delhi Video |
| Advances in Sickle Cell Disease Treatment: A Comparative Review of HSCT and Gene Therapy (Casgevy & Lyfgenia) Omer Tarig Fathi Abdelazim1, Abu-Baker Khalid Sharafeldin1, Mohammed Kawari2, Zahra Abdulla Isa Yusuf Hasan3, Zainab Abdulmajeed Toorani4 1School of Medicine, RCSI—Medical University of Bahrain, Adliya, Capital Governorate, Bahrain; 2Saskatchewan Cancer Agency, University of Saskatchewan, Regina, Canada; 3MBBChBAO, MRCPUK, Senior Hematology Specialty Registrar, Redditch, UK; 4Ministry of Health, MBBChBAO, RCSI-MUB Clinical Pathology Tutor & Specialist Anatomical Pathologist at SalmaniyaMedical Complex, Manama, Bahrain |
| AI in Hematology: A New Frontier for Nursing Practice and Patient Care Abdelrahman Nasiri1, Nebras A. Alsalman2, Fai A. Aljandabi2, Sarah A. Alsomali2 1College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh; 2Medical Oncology & Hematology, Cancer Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudia Arabia |
| ATYPICAL BCR-ABL SIGNAL PATTERNS IDENTIFIED BY FLUORESCENCE IN SITU HYBRIDIZATION IN VARIOUS HEMATOLOGICAL DISORDERS & ITS IMPACT ON PROGNOSIS Aima Nasir Bukhari, Shawana Shahid, Omama Hania Shifa International Hospital, Islamabad, Pakistan Video |
| Balancing the Fight Against Multiple Myeloma and Quality of Life Deivid Badalian1,2, Artem Oganesyan3, Lusine Sahakyan2, Alita Nikoghosyan1, Arman Vardevaryan1, Davit Melkonyan1, Yervand Hakobyan1,2 1National Institute of Health, Ministry of Health of the Republic of Armenia; 2Yeolyan Hematology and Oncology Center, Armenia; 3Department of Internal Medicine, Jefferson Abington Hospital, PA, USA Video |
| CLINICO HEMATOLOGICAL STUDY OF BONE MARROW INVOLVEMENT IN NON-HEMATOLOGICAL MALIGNANCY Ruchee Khanna, Akshay Aditya Department of Pathology, Kasturba Medical College and Manipal Academy of Higher Education, Mahe, Manipal Video |
| DISPARITY IN ACCESS TO GENE THERAPY: ADDRESSING HEALTH EQUITY IN AFRICA’S FIGHT AGAINST SICKLE CELL DISEASE Patrick Ashinze1, Nelson Mafua2, Lukman Abiodun Musa3, Princess Alabi1, Peter Ayodele1, Oluwadamilare Olatunbosun4, Toluwanimi Olatunbosun4, Hamdallah Modupe Alausa1, Yetunde Morayo Oladipupo5, Gabriel Oluwatosin Afolabi1, Akintola Akinwunmi1 1Faculty of Clinical Sciences, University of Ilorin Teaching Hospital, Ilorin, Nigeria; 2Faculty of Clinical Sciences, Madonna University, Anambra, Nigeria; 3Emergency Department, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, Scotland; 4 Obafemi Awolowo University Teaching Hospital Complex, Ife, Nigeria; 5 – University College Hospital, Ibadan, Nigeria |
| Evaluation of thrombophilia profile: frequency and presentation – Prevalence and Clinical Spectrum of Hereditary Thrombophilia among Patients with Venous Thromboembolism Omama Abbasi, Ayesha Junaid, Maryam Habib, Aima Nasir, Hania Ejaz Shifa International Hospital, Islamabad, Pakistan Video |
| Flow Cytometric Analysis of TCL1 Expression in Hematologic Malignancies and Normal or Reactive Blood and Bone Marrow Cells A. Kotsiafti1, C. Karela1, G. Oudatzis1, M. Milaiou1, K. Mandaraka1, P. Vasileiou2, N. Tsagkarakis3, G. Paterakis1 1Department of Immunology, Athens General Hospital “G. Gennimatas”; 2“Flowdiagnosis” Diagnositc Center; 3Hematology Laboratory, Athens General Hospital “G. Gennimatas”, Athens, Greece |
| HAEMATOLOGICAL AND VASCULOPATHIC COMPLICATIONS OF SEVERE MALARIA – A SYSTEMATIC REVIEW OF CURRENT EVIDENCE, MANAGEMENT MODALITIES, AND FUTURE DIRECTIONS Patrick Ashinze1, Daniel Olumuyiwa Ogunruku2, Jasmine Kaur3, Ebubechukwu Nzubechukwu Eriobuna4, Kenneth Nwafor5, Mayowa Ebenezer Olagoke6 1University of Ilorin Teaching Hospital, Ilorin, Nigeria; 2Texila American University, Georgetown, Guyana; 3Gian Sagar Medical College, India; 4University College Hospital, Ibadan, Nigeria; 5University of Uyo Teaching Hospital, Uyo, Akwa Ibom, Nigeria; 6Health Education, England, UK |
| IMPACT OF GOVERNMENT HEALTH INSURANCE SCHEME ON ACCESS TO TREATMENT IN PATIENTS WITH NEWLY DIAGNOSED LEUKEMIA: A REAL-WORLD ANALYSIS Thejeswar N. Prakasham, Meher Lakshmi Konatam, Rachana Chenemmaneni, Vishnu Kumar Samala, Leela Krishna, Sadashivudu Gundeti Department of Medical Oncology, Nizam’s Institute of Medical Sciences, Hyderabed, India Audio |
| Laboratory and clinical outcomes in patients with heparin-induced thrombocytopenia – single center experience A Bankova1, E. Doncheva2, G. Vasilev1, A. Banchev1, I. Pascaleva2 1Specialized Hospital for Active Treatment of Hematological Diseases, Sofia; 2National Hospital of Cardiology, Sofia, Bulgaria Video |
| Memantine Treatment in Sickle Cell Disease: A One-Year Study of Its Effects on Cognitive Functions and Neural Processing Sivan Raz1,2, Ariel Koren3,4, Anna Yu Bogdanova5, Max Gassmann6, Carina Levin3,4 1Department of Psychology, The Per Sternberg EEG-ERP Laboratory for the Study of Brain and Behavior, Tel-Hai College, Israel; 2Department of Behavioral Sciences, The Center for Psychobiological Research, The Max Stern Yezreel Valley College, Israel; 3Pediatric Hematology Unit, Emek Medical Center, Afula, Israel; 4The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel; 5Red Blood Cell Research Group, Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zürich, Switzerland; 6Institute of Veterinary Physiology, Vetsuisse Faculty, and the Zurich Center for Integrative Human Physiology (ZIHP), University of Zürich, Switzerland Video |
| Navigating Tradition and Modernity: A Pilot survey of traditional remedy use in Saudi adults with Sickle Cell Disease Abdulrahman Nasiri1, Albaraa Madkhali2, Yahya Hummadi1 1College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh; 2Department of Internal Medicine, Armed Forces Hospital, Jizan; 3King Faisal Specialist Hospital & Research Centre, Hematology Department, Riyadh, Saudi Arabia |
| Safety of Bone Marrow Biopsy in Patients Receiving Anticoagulation Therapy: A Systematic Review and Meta Analysis Abdulrahman Nasiri1, Manal Alshammri2, Rawan Alqahtani3, Hamad Alghethber4, Reem Alkharras4 1College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh; 2Department of Hematology, Oncology Center, King Salman Specialist Hospital, Hail; 3Department of Pharmacy, Security Forces Hospital, Riyadh; 4Department of Internal Medicine, Security Forces Hospital, Riyadh, Saudi Arabia |
| SERUM SELENIUM LEVEL IN NEUTROPENIC SUBJECTS ATTENDING KWARA STATE UNIVERSITY TEACHING HOSPITAL ILORIN, KWARA STATE, NIGERIA Musa Ahmeda1, Ayodele Ilesanmia1, Muhammad Nurudeena1, Muhammed Olaitan Hamzaha1, Ibraheem Qoseem Olasunkanmia1, Abdulraheem Hamzata1, Sheu Olayinka Okanlawonb2 1Department of Hematology, School of Medical Laboratory Science, Kwara State University, Malete; 2Medical Laboratory Science Council of Nigeria, Kwara State, Nigeria Video |
| SGLT2 INHIBITOR-ASSOCIATED POLYCYTHAEMIA: A HAEMATOLOGY PERSPECTIVE FROM A RETROSPECTIVE CASE SERIES Sarah Fathima, Fauzia Wasim, Syed Aaquil Hasan University Hospitals of North Midlands NHS Trust |
| The impact of ABO major mismatching of platelet transfusions in oncohematology patients Brahim Khachaa, Amine Moueden, Reda Messaoudi, Hacene Brouk, Assia Bouhadjar University Hospital of Oran, Algeria Video |
| TRAVEL MEDICINE FOR SICKLE CELL DISEASE: MAPPING THE RESEARCH LANDSCAPE Abdulrahman Nasiri1, Manal Alshammri2, Mostafa Saleh3, Reem Alkharras4 1College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh; 2Department of Hematology, Oncology Center, King Salman Specialist Hospital, Hail; 3King Faisal Specialist Hospital & Research Center, Hematology Department, Riyadh; 4Department of Internal Medicine, Security Forces Hospital, Riyadh, Saudia Arabia |
| Treating Multiple Myeloma – ten years’ experience of a National Cancer Research Center of Serbia Andrijana Kojic, Mila Puric Institute for Oncology and Radiology of Serbia, Belgrade, Serbia Video |
| TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH VENETOCLAX: EXPERIENCE OF A SINGLE CENTER IN BELARUS Oksana Morozova, Tatsiana Talako, Alena Kuzmich, Alena Dziuba, Oksana Nechay, Yuri Strongin, Victoria Smolnikova, Viktoryia Hrynevich, Tatiana Lebedeva, Natallia Kokhnovich, Nataly Milanovich, Anatoly Uss Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology, Minsk, Belarus Video |
| UPFRONT COMPREHENSIVE DONOR SEARCH OUTCOMES OVERCOME THE IMPACT OF POOR SEARCH PROGNOSIS, IRRESPECTIVE OF RACIAL BACKGROUND Fei Fang1,2, Ryan Vethanayagam1,5, Karen R. Sherwood3, James Lan3, Matthew Seftel4, Yasser R. Abou Mourad1,2, Hannah M. Cherniawsky1,2, Shanee S. Chung1,2, Donna L. Forrest1,2, Paul Keown3, Florian C. Kuchenbauer1,2, Stephen H. Nantel1,2, Judith A. Rodrigo1,2, ArefehRouhi2, Claudie Roy1,2, David Sanford1,2, Kevin W. Song1,2, Ryan J. Stubbins1,2, Cynthia L. Toze1,2, Jennifer K. White1,2, Sujaatha Narayanan1,2, Thomas J. Nevill1,2, Deepesh P. Lad1,2 1Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, BC, Canada; 2Division of Hematology, Department of Medicine, 3Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada; 4Canadian Blood Services, BC, Canada; 5University of Limerick, School of Medicine, Limerick, Ireland |
PostersAdam Barkay2025-10-08T20:40:30+00:00